Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2009 | 04-2009 | 01-2009 | 12-2008 | 10-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10 | -8 | -1 | 0 | N/A |
| Depreciation Amortization | 1 | 1 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | -4 | -1 | -4 | 0 | N/A |
| Other Working Capital | -4 | -1 | -4 | N/A | N/A |
| Other Operating Activity | 4 | 1 | 4 | 0 | 0 |
| Operating Cash Flow | $-12 | $-8 | $-5 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10 | 5 | 2 | 0 | N/A |
| Financing Cash Flow | $10 | $5 | $2 | $0 | $N/A |
| Beginning Cash Position | 3 | 3 | 3 | 0 | N/A |
| End Cash Position | 1 | 0 | 0 | 0 | N/A |
| Net Cash Flow | $-3 | $-3 | $-3 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -12 | -8 | -5 | 0 | N/A |
| Free Cash Flow | -12 | -8 | -5 | 0 | 0 |